drugset
drugset / Trial / NCT06345716

Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic

NCT06345716 ↗

Phase 2 Recruiting 1500 enrolled University of Monastir
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group.

Timeline

Start
2024-04-10
Primary completion
2025-03-15
Completion
2025-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 325 mg Oral
Subject Acetaminophen Small molecule 500 mg Oral
Subject Caffeine Small molecule 65 mg Oral
Subject Tramadol Other / unclassified 37.5 mg Oral

Indications

urinary tract obstruction